Gout and Uric & Nucleic Acids
Instruction for authors(Revised on May 16, 2020)

1. Requirements for the submission of manuscripts.
The first and corresponding authors have to be members of this academic society, except for
authors of review papers invited by the editorial committee.

2. Types of papers
Gout and Uric & Nucleic Acids is published half-yearly. We accept original articles, review
papers, case and brief reports, and other papers on gout and uric/nucleic acid metabolism. Papers
that have already been published in/submitted to other journals cannot be accepted.

Original Articles
Original articles must be written in the following order: the title, the names of authors,affiliations, key words, Abstract (the word limit is 250 words), Introduction, Methods (ResearchMethods, Case Examples), Results, Discussion, Acknowledgement, COI, References.
Format: (1) Manuscripts must be written on A4 paper with up to 4,000 words. The numbers ofwords from the Abstract to COI, including tables, and figures (each Table or Figure
equivalent to 100 words), are counted. Characters/words in References are not included.
(2) The cover page of the manuscript should contain the title, the full names of theauthors and the organizations. You may add your maiden name. It should also containup to five key words, and the contact information of the corresponding author, including
a telephone number, fax number, and e-mail address.
Review Articles
Review articles are published based on requests by the editorial committee. However, membersof the society are allowed to submit manuscripts written on subjects of their interest, which will1

undergo screening. Review articles should be written in the same format as that of originalarticles, with up to 4,000 words.
Case reports/ Brief Reports
Case and brief reports should be written according to the guidelines for original articles. Thesereports should be written in the same format as that of original articles. The numbers of words forcase reports must be 4000 or less. The numbers of words for brief reports must be 400 or less.

3. Method for submission of papers
Manuscripts should be sent to the following e-mail address together with abstracts, tables,figures, and pictures. “The name of the first author” should be used as the title of the body text file,and table and figure files should be titled “Figure 1”, “Table 2”, etc. Use MS Word for the body text
and tables, and PDF or TIF format should be used for figures. If authors wish to submit manuscripts
using other file formats (rich text file, JPG, etc.), contact the editorial office. Please include PDF
files of the complete manuscript to check for garbled characters and color aberration.

*Submit manuscripts to/contact the following to ask questions about editing:

Editorial Office: Gout and Uric & Nucleic Acids
First Department of Internal Medicine, University of Fukui School of Medical Sciences
23-3, Matsuoka-shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, JAPAN
Tel: +81-776-61-8343
Fax: +81-776-61-8109
E-Mail: tyamauch@u-fukui.ac.jp*If you wish to become a member of the Japanese Society of Gout and Uric & Nucleic Acids,
please visit our website (http://www.tukaku.jp). The bank transfer form to pay annual membershipfees will be sent to you following the acceptance of the application.
2

The office of the Japanese Society of Gout and Uric & Nucleic Acids
Fukutoku Bldg. 3F, 1-11-15 Nishi-shimbashi Minatoku, Tokyo 105-0003
Editorial Office of the Japanese Society of Gout and Uric & Nucleic Acids
TEL 03-5512-3326

FAX 03-3593-8303

E-Mail: info@tukaku.jp

4. Manuscript preparationa. Figures must be clear enough to be printed as they are.
b. The References should be formatted as follows:a) Superscript numbers corresponding to the numbers in the Reference should be written
in the upper-right of each citation with a bracket in the order of citation.
b) Format[Journal]: Name of the author, title of the paper, name of the journal, volume: the first- last pages, year of publication[Books]: Name of the author, title of the paper, name of the book, name of the editor,
publisher, the first - last pages, year of publicationc) Names of up to three authors (in the order of the last and first names) should be written
accompanied with “et al.” (if the number of authors is more than three).
d) Abbreviated names of journals should comply with Index Medicus.
Example: 1) Hanayama H: Renal diseases associated with chronic rheumatoid arthritis.
Rheumatism 3: 363-365,1972.
2) Walker BR, Hoppe RC, Alexander F, et al: Effect of triamteren on the renal
clearance of calcium, magnesium, phosphate, and uric acid in man. Clin
Pharmacol Ther 13: 245-250, 1972.
3) Wyngaarden JB, Kelley WN: Production of Uric Acid in Primary Gout. Goutand Hyperuricemia, Grune & Stratton, pp133-148, 1976.
34) Seegmiller JE: Diseases of purine and pyrimidine metabolism. Duncan’s
Diseases of Metabolism, Bondy PK, Posenberg LE (eds), 7th ed. W.B.
Saunders Company, Philadelphia, pp 655-656, 1974.
c. Although the editorial board exerts its best efforts to insert tables and figures in specified
areas, authors’ requests may not be fulfilled if there are large numbers of tables and figures.
(Please limit the numbers of tables and figures).
d. Please note that we use our standard styles to format the journal.
Example: Units for metrological standards should be written using the following print
letters without the ellipsis.
µL mL dL: µg mg g kg: nm mm cm: sec min hr: nM μM mM M: nmol μmol
mmol mole. The authors are required to comply with the following ethics guidelines: The Declaration ofHelsinki (adopted in 1964 and revised in the World Medical Association General Assemblyat Tokyo [1975], Venice [1983], Hongkong [1989], Somerset West [1996], Edinburgh[2000], Seoul [2008], and Fortaleza [2013]; Ethical Guidelines for Medical and HealthResearch Involving Human Subjects (Ministry of Education, Culture, Sports, Science andTechnology/Ministry of Health, Labour and Welfare: published on December 22, 2014);“The Ethical Guidelines for Epidemiological Research” for Survey Research (completelyrevised on June 17, 2002, and December 28, 2004, partially revised on June 29, 2005,
completely revised on August 16, 2007, partially revised on December 1, 2008); “TheStandard for Care and Management of Laboratory Animals and Relief of Pain.” forResearch involving Animals (published on April 28, 2006, and finally revised in 2013), andstipulate other governing laws and regulations on an as-required basis.
f. As for the approval of the ethics committee, clinical trials need to undergo screening
conducted by the facilities or relevant public organizations. Please describe whether or notclinical trials have been approved in the body text.

45. Proofreading
When authors proofread their accepted manuscripts, they must not add or delete sentences.
The editorial department also proofreads English papers. However, if authors who haveproofread their English papers do not request English proofreading, please inform the editorial
department following the acceptance of the paper. Manuscripts that have undergone only English
proofreading by authors themselves will also be accepted.

6. Publication fee: No publication fee is required.

7. Copyright
Copyright of materials published in the journal is owned by the Japanese Society of Gout andUric & Nucleic Acids. Papers published in the journal will be available on the Internet (website ofthe academic society). When using a part of materials, such as tables and figures, published in thejournal, please submit “a request for permission for reprinting/using materials” to obtain theapproval of the editorial chief.
When the objectives of reprints to other journals or electronic citations are considered to be otherthan academic purposes, permission fees will be required and paid to the Japanese Society of Goutand Uric & Nucleic Acids.

8. Conflicts of Interest disclosure by authors who submit papers
The disclosure of Conflicts of Interest (COI) by authors should be written below the body textand Acknowledgement and above References. Authors should disclose the declaration of COI when
they submit papers. Please download the prescribed form from the following website:(http://www.tukaku.jp/secretariat/coi.html)

Methods for COI disclosure:(1) When there is no declaration of COI to be disclosed:
5

Example: Disclosure of the authors’ COI (conflicts of interest): There is no declaration of COI
regarding this paper.
(2) When there are declarations of COI to be disclosed:
Disclosure of the declaration of COI (conflicts of interest): Authors should write the names ofcompanies, institutions, and organizations that have COI with each author regarding rewards,
profits from stocks, patent royalties, fees for lectures, manuscript fees, research grants/subsidies,
donations, lectures supported by donations, travel expenses/gifts (in this order).
Example:Authors’ COI (conflicts of interest) Disclosure: Tanaka Ichiro; lecture fees ( Pharmaceutical,
 Pharmaceutical), donations ( Pharmaceutical,  Pharmaceutical), Tanaka Jiro; lecture
fees ( Pharmaceutical), research grants/subsidies( Pharmaceutical), donations (Pharmaceutical,  Pharmaceutical), Tanaka Saburo; lecture fees ( Pharmaceutical, Pharmaceutical), lectures supported by donations ( Pharmaceutical), travel expenses/gifts (Pharmaceutical)

6